↓ Skip to main content

Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)

Overview of attention for article published in BMC Immunology, December 2021
Altmetric Badge

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
6 Mendeley